BPMC

Blueprint Medicines Corporation

Price

return (12m)

p/e

-53.20

p/bv

24.22

DIVIDEND YIELD

0.00%

BPMC price

Blueprint Medicines

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment BPMC

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals BPMC

Valuation

P/E

-53.20

Sector -3.50

Industry -3.50

P/BV

24.22

Sector 2.02

Industry 2.02

P/Revenue (PSR)

14.74

Sector 2.01

Industry 2.01

EV/EBITDA

341.96

Sector -214.99

Industry -214.99

EV/EBIT

421.85

Sector -47.59

Industry -47.59

P/EBITDA

-124.74

Sector -21.41

Industry -21.41

P/EBIT

-100.60

Sector -28.65

Industry -28.65

P/Total Assets

6.93

Sector 1.19

Industry 1.19

P/Net Current Assets

-54.73

Sector -11.97

Industry -11.97

P/Working Capital

18.35

Sector -167.95

Industry -167.95

EPS

-2.43

Sector -1.81

Industry -1.81

BVPS

5.35

Sector 2.06

Industry 2.06

Efficiency

Gross Margin

96.48%

Sector 41.30%

Industry 41.30%

EBITDA Margin

15.76%

Sector -17,117.21%

Industry -17,117.21%

EBIT Margin

12.78%

Sector -4,185,659.35%

Industry -4,185,659.35%

Operating Margin

-31.01%

Sector -35.21%

Industry -35.21%

Net Profit Margins

-27.70%

Sector -35.91%

Industry -35.91%

Asset Turnover

0.12

Sector 0.02

Industry 0.02

Profitability

ROE

-45.52%

Sector -56.04%

Industry -56.04%

ROA

-13.03%

Sector -60.31%

Industry -60.31%

ROIC

-9.60%

Sector -2,335.95%

Industry -2,335.95%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

2.80

Sector 2.89

Industry 2.89

Net Debt / EBITDA

-9.86

Sector -14,066,680.10

Industry -14,066,680.10

Net Debt / EBIT

-12.17

Sector -8.06

Industry -8.06

Net Debt / Equity

-0.68

Sector -33,024.69

Industry -33,024.69

Gross Debt / Equity

1.01

Sector -0.85

Industry -0.85

Equity/Assets

0.29

Sector 0.46

Industry 0.46

Liabilities/Assets

0.71

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

19.68%

Sector -

Industry -

5Y Earnings CAGR

-24.72%

Sector -

Industry -

Fundamentals BPMC

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
BPMC Blueprint Medicines Corporation	$0.00	-	0.00%	-53.20	24.22	-45.52%	-27.70%
JNJ Johnson & Johnson	$269.33	55.44%	1.96%	30.82	7.63	24.76%	21.48%
PFE Pfizer Inc.	$27.49	22.33%	6.26%	35.85	1.83	5.11%	6.86%
ABBV AbbVie Inc.	$263.93	23.34%	2.59%	73.99	-78.76	-106.44%	9.81%
NVO Novo Nordisk A/S	$43.19	-26.70%	4.29%	10.56	5.61	53.11%	35.32%
MRK Merck & Co. Inc.	$146.11	87.14%	2.31%	113.21	8.55	7.55%	4.76%
AZN AstraZeneca PLC	$166.35	9.78%	1.94%	19.88	5.12	25.77%	16.95%
BMY Bristol-Myers Squibb Company	$62.71	43.77%	4.04%	13.67	5.68	41.55%	18.85%
ZTS Zoetis Inc.	$72.66	-49.60%	2.88%	11.47	9.64	84.02%	27.77%
AMGN Amgen Inc.	$383.04	43.28%	2.60%	23.66	17.70	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$784.44	31.54%	0.47%	18.63	2.54	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$111.35	46.87%	0.00%	31.57	90.97	288.13%	24.86%
MCK McKesson Corporation	$874.67	27.00%	0.38%	19.57	-26.84	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$506.08	30.72%	0.00%	29.15	6.34	21.76%	35.00%
CAH Cardinal Health Inc.	$224.45	52.89%	0.91%	30.53	-19.32	-63.29%	0.68%
ARGX argenx SE	$994.44	35.42%	0.00%	2.24	2.63	117.11%	44.68%
HRMY Harmony Biosciences Holdings Inc.	$42.23	31.71%	0.00%	13.50	2.45	18.14%	18.88%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

BPMC Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Blueprint Medicines

Blueprint Medicines Corporation

Average Investor10 user rating

4.0 (0 people)

United States

18 years

Founded: 2008

2015

Time since IPO - 11 years

383

Employees

Blueprint Medicines Corporation (United States) is listed on the Nasdaq and has a market capitalization of $8.29 billion, with shareholders equity totaling $342.13 million.

The company employs approximately 383 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Blueprint Medicines Corporation reported $562.12 million in revenue, generating net income of $-155.73 million.

Key financial metrics include a P/E ratio of -53.20, a price-to-book (P/B) ratio of 24.22, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker BPMC.

Market cap

$8.29 billion

Net worth

$342.13 million

$342,130,000.00

Assets

$1.20 billion

$1,195,600,000.00

Total Shares Outstanding

64.00 million

64,000,000

Average Daily Trading Volume

$4.32 million

$4,318,064.12

Sector

Health Care

Industry

Biotechnology

BPMC

BPMC revenue and profits

Financial Results BPMC

DRAG THE FRAME TO SEE MORE DATA

BPMC cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$874.67 25,76% (12M)

P/E

19.57

0.38%

ROE

-137.16%

P/BV

-26.84

CAH - Cardinal Health

$224.45 51,61% (12M)

P/E

30.53

0.91%

ROE

-63.29%

P/BV

-19.32

JNJ - Johnson & Johnson

$269.33 56,33% (12M)

P/E

30.82

1.96%

ROE

24.76%

P/BV

7.63

ABBV - AbbVie

$263.93 22,42% (12M)

P/E

73.99

2.59%

ROE

-106.44%

P/BV

-78.76

MRK - Merck & Co.

$146.11 85,19% (12M)

P/E

113.21

2.31%

ROE

7.55%

P/BV

8.55

AZN - AstraZeneca

$166.35 9,17% (12M)

P/E

19.88

1.94%

ROE

25.77%

P/BV

5.12

PFE - Pfizer

$27.49 22,43% (12M)

P/E

35.85

6.26%

ROE

5.11%

P/BV

1.83

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$874.67 25,76% (12 M)

P/L

19.57

0.38%

ROE

-137.16%

P/VP

-26.84

CAH - Cardinal Health

$224.45 51,61% (12 M)

P/L

30.53

0.91%

ROE

-63.29%

P/VP

-19.32

JNJ - Johnson & Johnson

$269.33 56,33% (12 M)

P/L

30.82

1.96%

ROE

24.76%

P/VP

7.63

ABBV - AbbVie

$263.93 22,42% (12 M)

P/L

73.99

2.59%

ROE

-106.44%

P/VP

-78.76

MRK - Merck & Co.

$146.11 85,19% (12 M)

P/L

113.21

2.31%

ROE

7.55%

P/VP

8.55

AZN - AstraZeneca

$166.35 9,17% (12 M)

P/L

19.88

1.94%

ROE

25.77%

P/VP

5.12

PFE - Pfizer

$27.49 22,43% (12 M)

P/L

35.85

6.26%

ROE

5.11%

P/VP

1.83

Frequently Asked Questions

What is the price of Blueprint Medicines (BPMC) today?

A cotação de Blueprint Medicines (BPMC) hoje está em US$ 0.00, com uma variação de 0% em relação ao último ano. A cotação de Blueprint Medicines (BPMC) iniciou o ano negociando na casa dos US$ 0.00 e hoje está em US$ 0.00. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Blueprint Medicines (BPMC) e dados de ações do Ibovespa e mercados internacionais.

Quando Blueprint Medicines (BPMC) paga dividendos?

Blueprint Medicines (BPMC) não distribuiu dividendos no último ano.

Is Blueprint Medicines (BPMC) a good investment?

Atualmente, Blueprint Medicines (BPMC) está cotada a US$ 0.00, com um P/L de -53.20, representando um desvio de -3,789% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 0 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Blueprint Medicines (BPMC) stock?

Investir em ações de Blueprint Medicines (BPMC) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Blueprint Medicines (BPMC) yield today?

A rentabilidade de Blueprint Medicines (BPMC) foi de 0.00% no último mês, 0.00% no último ano e 0.00% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Blueprint Medicines (BPMC) hoje, o investimento total seria de US$ 0.00, com base na cotação atual de US$ 0.00.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 0.00
Em 5 anos: US$ 0.00
Em 10 anos: US$ 0.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

BPMC

Blueprint Medicines Corporation

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment BPMC

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING BPMC WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Blueprint Medicines

Blueprint Medicines Corporation

United States

18 years

2015

383

PROFIT X PRICE BPMC

Financial Results BPMC

BPMC cash flow

Asset, Revenue and Profit Growth - BPMC

BPMC balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions